0:00
16:42
Welcome to Health Conversation. Today we're asking Peter Guenter, CEO of Healthcare at Merck, 'What would be the impact of a TRIPS waiver extension?'. Listen to hear their discussion on the challenge and how we're preparing for the future.
Hosted on Acast. See acast.com/privacy for more information.
Weitere Episoden von „Health Conversation“
Verpasse keine Episode von “Health Conversation” und abonniere ihn in der kostenlosen GetPodcast App.